Dan Grisaru
Gynecologic oncologist, work experience: over 35 years. Head of the Gynecologic Surgery Department in the Ichilov Hospital.
- Surgical treatment of malignant tumors of the uterus, ovaries, vagina.Surgical treatment of malignant tumors of the uterus, ovaries, vagina. Early diagnosis of these cancers. Israeli doctors are often able to preserve fertility in gynecologic cancer patients thanks to timely cancer detection. In Israel, most surgical procedures are organ-preserving: the patients' quality of life is not diminished.
- Polycystic ovary syndrome
- Adenomyosis treatment
- Cervical cancer
- Ovarian cysts
- Vaginal cancer
- Ovarian Cancer
- Uterine Cancer
- Russian
- English
- Hebrew
-
Tel Aviv University, Professor of the Department of Obstetrics and Gynecology -
University of Toronto (Canada), specialization in gynecologic oncology -
Hebrew University of Jerusalem, Faculty of Medicine
-
2001-2011Head of Gynecologic Oncology Department, Ichilov – Sourasky Medical Complex
-
2011-2017Chief Physician of Gynecologic Oncology Department, Ichilov – Sourasky Medical Complex in Israel
-
American Society of Gynecologic Oncology -
Canadian Society of Gynecologic Oncology -
Israel Society of Obstetrics and Gynecology -
Israel Society of Gynecologic Oncology
Professor Grisaru Talks about Ovarian Cancer Treatment:
“Ovarian cancer treatment consists of 2 parts.
The 1st part is surgery. One or both ovaries are removed depending on the stage of cancer at the time of diagnosis. Most often, ovarian cancer is diagnosed in advanced stages. In this case, the doctor removes not only the ovaries, but also uterus and the whole tumor that has spread beyond the ovaries into the abdominal cavity.
We strive for complete removal of the tumor from the abdominal cavity!
The 2nd part of treatment is drug therapy. This is chemotherapy commonly prescribed after surgery. Sometimes, when we suspect that complete removal of the tumor from the abdominal cavity will be difficult, we start with chemotherapy and then perform surgery.
In addition to surgery, we may perform intraperitoneal chemotherapy that involves administration of drugs into the open abdominal cavity. If tumor cells remain there, they will be destroyed.
Nowadays, we tend to avoid systemic chemotherapy that affects both cancerous and healthy cells. We prefer targeted therapy. Unlike conventional chemotherapy, targeted therapy is a biological treatment.
Cancerous cells are altered cells that differ from normal ones. The understanding of the cellular changes helps us target and destroy these cells. For instance, ovarian cancer is treated with the Avastin targeted drug also used for breast cancer treatment”.
